- Denosumab for treatment of hypercalcemia of malignancy. The Journal of clinical endocrinology and metabolism. 2014 Academic Article GET IT
- Denosumab for patients with persistent or relapsed hypercalcemia of malignancy despite recent bisphosphonate treatment. Journal of the National Cancer Institute. 2013 Academic Article GET IT
Optimal calcium intake. Sponsored by National Institutes of Health Continuing Medical Education.
Times cited: 16
NIH Consensus conference. Optimal calcium intake. NIH Consensus Development Panel on Optimal Calcium Intake.
Journal of the American Medical Association.
Times cited: 385
- Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. The Journal of clinical investigation. 1988 Academic Article GET IT
- In vitro adenylate cyclase-stimulating activity predicts the occurrence of humoral hypercalcemia of malignancy in nude mice. The Journal of clinical investigation. 1988 Academic Article GET IT